Latest News
Acadia Pharmaceuticals Inc.
- Acadia Pharmaceuticals announces retirement of R&D head, names interim consultant
- Form 8K ACADIA Pharmaceuticals Inc For: 23 October By Investing.com
- Acadia Pharmaceuticals to report Q3FY26 results on November 4
- Acadia Pharmaceuticals Stock Extends A 7-Day Losing Streak To A 25% Loss
- Acadia Pharmaceuticals drops 7%, continuing fall after drug trial results (ACAD:NASDAQ)
- Acadia Pharmaceuticals (ACAD) Shares Drop After Phase 2 RADIANT Study Results
- Acadia chugs on with Alzheimer’s psychosis programme despite Phase II miss
- Acadia Pharmaceuticals stock tumbles on mixed trial results
- Acadia touts 'Phase III-enabling' data despite miss in Alzheimer's psychosis
- Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing
- TD Cowen reiterates Acadia Pharmaceuticals stock rating on trial data By Investing.com
- Why is ACADIA Pharmaceuticals stock sliding today?
Headlines from the last 30 days, linking to the original publishers. See all market news →